Cargando…
Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
Tumor necrosis factor (TNF) is a pleiotropic cytokine involved in many aspects of immune regulation. Anti-TNF biological therapy has been considered a breakthrough in the treatment of chronic autoimmune diseases, such as rheumatoid arthritis (RA). In this review, because of the major involvement of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235207/ https://www.ncbi.nlm.nih.gov/pubmed/30314507 http://dx.doi.org/10.1186/s13075-018-1725-6 |
_version_ | 1783370834482561024 |
---|---|
author | Davignon, Jean-Luc Rauwel, Benjamin Degboé, Yannick Constantin, Arnaud Boyer, Jean-Fredéric Kruglov, Andrey Cantagrel, Alain |
author_facet | Davignon, Jean-Luc Rauwel, Benjamin Degboé, Yannick Constantin, Arnaud Boyer, Jean-Fredéric Kruglov, Andrey Cantagrel, Alain |
author_sort | Davignon, Jean-Luc |
collection | PubMed |
description | Tumor necrosis factor (TNF) is a pleiotropic cytokine involved in many aspects of immune regulation. Anti-TNF biological therapy has been considered a breakthrough in the treatment of chronic autoimmune diseases, such as rheumatoid arthritis (RA). In this review, because of the major involvement of T cells in RA pathogenesis, we discuss the effects of anti-TNF biotherapy on T-cell responses in RA patients. We also outline the potential fields for future research in the area of anti-TNF therapy in RA. This could be useful to better understand the therapeutic efficiency and the side effects that are encountered in RA patients. Better targeting of T cells in RA could help set more specific anti-TNF strategies and develop prediction tools for response. |
format | Online Article Text |
id | pubmed-6235207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62352072018-11-20 Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review Davignon, Jean-Luc Rauwel, Benjamin Degboé, Yannick Constantin, Arnaud Boyer, Jean-Fredéric Kruglov, Andrey Cantagrel, Alain Arthritis Res Ther Review Tumor necrosis factor (TNF) is a pleiotropic cytokine involved in many aspects of immune regulation. Anti-TNF biological therapy has been considered a breakthrough in the treatment of chronic autoimmune diseases, such as rheumatoid arthritis (RA). In this review, because of the major involvement of T cells in RA pathogenesis, we discuss the effects of anti-TNF biotherapy on T-cell responses in RA patients. We also outline the potential fields for future research in the area of anti-TNF therapy in RA. This could be useful to better understand the therapeutic efficiency and the side effects that are encountered in RA patients. Better targeting of T cells in RA could help set more specific anti-TNF strategies and develop prediction tools for response. BioMed Central 2018-10-12 2018 /pmc/articles/PMC6235207/ /pubmed/30314507 http://dx.doi.org/10.1186/s13075-018-1725-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Davignon, Jean-Luc Rauwel, Benjamin Degboé, Yannick Constantin, Arnaud Boyer, Jean-Fredéric Kruglov, Andrey Cantagrel, Alain Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review |
title | Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review |
title_full | Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review |
title_fullStr | Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review |
title_full_unstemmed | Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review |
title_short | Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review |
title_sort | modulation of t-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235207/ https://www.ncbi.nlm.nih.gov/pubmed/30314507 http://dx.doi.org/10.1186/s13075-018-1725-6 |
work_keys_str_mv | AT davignonjeanluc modulationoftcellresponsesbyantitumornecrosisfactortreatmentsinrheumatoidarthritisareview AT rauwelbenjamin modulationoftcellresponsesbyantitumornecrosisfactortreatmentsinrheumatoidarthritisareview AT degboeyannick modulationoftcellresponsesbyantitumornecrosisfactortreatmentsinrheumatoidarthritisareview AT constantinarnaud modulationoftcellresponsesbyantitumornecrosisfactortreatmentsinrheumatoidarthritisareview AT boyerjeanfrederic modulationoftcellresponsesbyantitumornecrosisfactortreatmentsinrheumatoidarthritisareview AT kruglovandrey modulationoftcellresponsesbyantitumornecrosisfactortreatmentsinrheumatoidarthritisareview AT cantagrelalain modulationoftcellresponsesbyantitumornecrosisfactortreatmentsinrheumatoidarthritisareview |